دورية أكاديمية
أعرض في EDS

Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia.

التفاصيل البيبلوغرافية
العنوان: Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia.
المؤلفون: Cartwright AF; FHI 360, Durham, NC, USA.; Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina (UNC), Chapel Hill, NC, USA., Callahan RL; FHI 360, Durham, NC, USA., Beksinska M; MRU (MatCH Research Unit), Department of Obstetrics and Gynecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa., Kasaro MP; Division of Global Women's Health, Department of Obstetrics and Gynecology, University of North Carolina (UNC), Chapel Hill, NC, USA., Tang JH; Division of Global Women's Health, Department of Obstetrics and Gynecology, University of North Carolina (UNC), Chapel Hill, NC, USA., Milford C; MRU (MatCH Research Unit), Department of Obstetrics and Gynecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa., Wong C; FHI 360, Durham, NC, USA., Velarde M; FHI 360, Durham, NC, USA.; Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina (UNC), Chapel Hill, NC, USA., Maphumulo V; MRU (MatCH Research Unit), Department of Obstetrics and Gynecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa., Fawzy M; FHI 360, Durham, NC, USA., Chinyama M; UNC Global Projects, Lusaka, Zambia., Chabu E; UNC Global Projects, Lusaka, Zambia., Mudenda M; UNC Global Projects, Lusaka, Zambia., Smit J; MRU (MatCH Research Unit), Department of Obstetrics and Gynecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa.
المصدر: Studies in family planning [Stud Fam Plann] 2023 Jun; Vol. 54 (2), pp. 379-401. Date of Electronic Publication: 2023 Feb 01.
نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 7810364 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1728-4465 (Electronic) Linking ISSN: 00393665 NLM ISO Abbreviation: Stud Fam Plann Subsets: MEDLINE
أسماء مطبوعة: Publication: Malden, MA : John Wiley & Sons Ltd
Original Publication: New York, Population Council.
مواضيع طبية MeSH: Intrauterine Devices, Copper*/adverse effects , Contraceptive Agents, Female*/adverse effects, Female ; Humans ; Levonorgestrel/adverse effects ; South Africa ; Zambia ; Contraception/methods
مستخلص: Few longitudinal studies have measured contraceptive continuation past one year in sub-Saharan Africa. We surveyed 674 women who had been randomized to receive the three-month intramuscular contraceptive injectable (DMPA-IM), levonorgestrel (LNG) implant, or copper intrauterine device (IUD) during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial in South Africa and Zambia and were subsequently followed for two additional years to explore method continuation, reasons for discontinuation, and access to implant and IUD removal services. We also conducted in-depth qualitative interviews with 39 participants. We estimated cumulative discontinuation probabilities using Kaplan-Meier estimates and assessed factors associated with discontinuation using Cox-proportional hazards models. The LNG implant continuation rate over the maximum 44-month study period was 60 percent, while rates for the copper IUD and DMPA-IM were 52 percent and 44 percent, respectively. Reasons for method discontinuation included side effects, particularly menstrual changes, and method stock-outs. Most implant and IUD users who sought removal were able to access services; however, room for improvement exists. In this cohort originally randomized to receive a contraceptive method and attend regular study visits, implants and IUDs continued to be highly acceptable over an additional two years, but facilities should continue to ensure that insertions and removals are available as requested.
(© 2023 The Authors. Studies in Family Planning published by Wiley Periodicals LLC on behalf of Population Council.)
References: Gates Open Res. 2017 Dec 29;1:17. (PMID: 29355224)
Glob Health Sci Pract. 2020 Oct 2;8(3):0. (PMID: 33008846)
Glob Health Sci Pract. 2016 Sep 29;4(3):366-72. (PMID: 27577239)
Contraception. 2015 Feb;91(2):93-6. (PMID: 25604899)
Am J Obstet Gynecol. 2015 Nov;213(5):662.e1-8. (PMID: 26259905)
Glob Health Sci Pract. 2018 Mar 30;6(1):17-39. (PMID: 29559495)
Hum Reprod. 2015 Nov;30(11):2527-38. (PMID: 26409014)
Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):795-806. (PMID: 24996766)
J Biomed Inform. 2019 Jul;95:103208. (PMID: 31078660)
Glob Health Sci Pract. 2020 Dec 23;8(4):666-679. (PMID: 33361234)
Stud Fam Plann. 2021 Sep;52(3):361-382. (PMID: 34383305)
Glob Health Sci Pract. 2020 Jun 30;8(2):220-238. (PMID: 32606092)
Contraception. 2009 May;79(5):356-62. (PMID: 19341847)
PLoS One. 2021 Sep 29;16(9):e0257769. (PMID: 34587200)
Cochrane Database Syst Rev. 2020 Jun 12;6:CD002126. (PMID: 32529637)
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005347. (PMID: 17943851)
BMC Musculoskelet Disord. 2021 May 28;22(1):489. (PMID: 34049528)
Stud Fam Plann. 2014 Jun;45(2):151-69. (PMID: 24931073)
Int Perspect Sex Reprod Health. 2013 Sep;39(3):133-41. (PMID: 24135045)
PLoS Med. 2020 May 22;17(5):e1003110. (PMID: 32442189)
Eur J Contracept Reprod Health Care. 2018 Aug;23(4):303-308. (PMID: 30198796)
Lancet Glob Health. 2018 May;6(5):e568-e578. (PMID: 29526707)
Lancet Glob Health. 2021 Oct;9(10):e1431-e1441. (PMID: 34474001)
Lancet. 2019 Jul 27;394(10195):303-313. (PMID: 31204114)
Contraception. 2018 Nov;98(5):379-382. (PMID: 30170029)
Glob Health Sci Pract. 2018 Dec 27;6(4):680-692. (PMID: 30591576)
Reprod Health. 2018 Jun 26;15(1):114. (PMID: 29940996)
معلومات مُعتمدة: P2C HD050924 United States HD NICHD NIH HHS
المشرفين على المادة: 5W7SIA7YZW (Levonorgestrel)
0 (Contraceptive Agents, Female)
تواريخ الأحداث: Date Created: 20230202 Date Completed: 20230605 Latest Revision: 20230611
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10239327
DOI: 10.1111/sifp.12222
PMID: 36727169
قاعدة البيانات: MEDLINE
الوصف
تدمد:1728-4465
DOI:10.1111/sifp.12222